Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chloé Manca"'
Autor:
Catherine Malaplate, Lucie Hopes, Chloé Manca, Thérèse Rivasseau Jonveaux, Antoine Verger, Véronique Roch, Amory Jardel
Publikováno v:
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease, IOS Press, 2021, 80 (4), pp.1389-1394. ⟨10.3233/JAD-201435⟩
Journal of Alzheimer's Disease, IOS Press, 2021, 80 (4), pp.1389-1394. ⟨10.3233/JAD-201435⟩
International audience; This longitudinal study evaluates the prognostic impact of amyloid PET in patients suspected of Alzheimer’s disease and presenting with isolated cerebrospinal fluid (CSF) increases in P-Tau proteins (NCT02556502). The rate o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fca2df36f3b8f3b2b5d414b34b9ce72
https://hal.univ-lorraine.fr/hal-03266987
https://hal.univ-lorraine.fr/hal-03266987
Autor:
Pierre-Yves Marie, Antoine Verger, Zohra Lamiral, Gilles Karcher, Catherine Malaplate, Chloé Manca, Thérèse Rivasseau Jonveaux, Véronique Roch
Publikováno v:
Journal of Neurology
Journal of Neurology, Springer Verlag, 2019, 266 (7), pp.1685-1692. ⟨10.1007/s00415-019-09315-y⟩
Journal of Neurology, Springer Verlag, 2019, 266 (7), pp.1685-1692. ⟨10.1007/s00415-019-09315-y⟩
International audience; Atypical cerebrospinal fluid (CSF) patterns, involving an increase in the concentration of phosphorylated-tau (P-tau) proteins but normal amyloid-β concentration, are not uncommon in patients with mild neurocognitive disorder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e2f71aac3634a18cf82b3ed77f066f
https://hal.archives-ouvertes.fr/hal-02144154/document
https://hal.archives-ouvertes.fr/hal-02144154/document
Autor:
Pierre-Yves Marie, Gilles Karcher, Véronique Roch, Antoine Verger, Lucie Hopes, Anna Kearney-Schwartz, Thérèse Rivasseau Jonveaux, Cédric Baumann, Catherine Malaplate-Armand, Chloé Manca
Publikováno v:
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease, IOS Press, 2019, 68 (3), pp.1061-1069. ⟨10.3233/JAD-181146⟩
Journal of Alzheimer's Disease, IOS Press, 2019, 68 (3), pp.1061-1069. ⟨10.3233/JAD-181146⟩
International audience; Background/objective: The aim of this study was to assess, in routine, the rates with which an amyloid deposition was documented by 18F-florbetaben PET in patients with suspected Alzheimer's disease (AD) but with isolated incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::866a4e561f357b2070be755a925e15e1
https://hal.univ-lorraine.fr/hal-03266997
https://hal.univ-lorraine.fr/hal-03266997
Autor:
Sébastien Gibot, Clément Drouet, Christine Selton-Suty, Pierre-Yves Marie, Hubert Tissot, Chloé Manca, François Goehringer
Publikováno v:
Nuclear medicine communications. 40(7)
Objectives To determine whether hypermetabolisms of the spleen and bone marrow and an enlarged adrenal gland are significant indirect signs of infection on fluorine-18-fluorodeoxyglucose (F-FDG) PET/CT performed in patients with known or suspected in
Autor:
C. Armand, Véronique Roch, Chloé Manca, Pierre-Yves Marie, Antoine Verger, Thérèse Rivasseau Jonveaux, Gilles Karcher
Publikováno v:
Médecine Nucléaire. 43:220
L’analyse semi-quantitative de la TEP aux marqueurs de la plaque amyloide est utile en complement a l’analyse visuelle standard, mais elle necessite classiquement de disposer des images d’IRM cerebrale des patients pour la normalisation spatial
Publikováno v:
Clinical Nuclear Medicine
Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2016, 41 (4), pp.e200-e201. ⟨10.1097/RLU.0000000000001103⟩
Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2016, 41 (4), pp.e200-e201. ⟨10.1097/RLU.0000000000001103⟩
International audience; Type I glycogen storage disease (GSD) is a rare autosomal recessive disorder caused by glucose-6-phosphatase deficiency. We report herein the particular pattern provided by FDG PET imaging in a 33-year-old patient with type Ib
Autor:
Gilles Karcher, Antoine Verger, Lucie Hopes, Pierre-Yves Marie, Thérèse Rivasseau Jonveaux, C. Armand Malaplate, A. Kearney Schwartz, Véronique Roch, Chloé Manca
Publikováno v:
Médecine Nucléaire. 42:135
La place de la TEP amyloide reste encore imprecise dans la strategie diagnostique de la maladie d’Alzheimer (MA). Pourtant, l’analyse du liquide cephalorachidien (LCR) ne permet pas toujours de confirmer le diagnostic. L’objectif de cette etude